1. RTI Surgical signed an agreement to acquire Cook Biotech.
2. Kuros Biosciences hit three advancements for its MagnetOS portfolio.
3. Ossium Health’s OssiGraft viable bone matrix allograft was used in its first patient case.
4. Legislation has been introduced in the U.S. House that would require all bone graft material to be tested for active and latent tuberculosis. It would also expedite the process for developing a screening test.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.